Kairos Pharma, LTD. KAPA
- KROS 401 — Triple Negative Breast Cancer Preclinical
IL-4 (3 companies · 3 programs)
Companies with an active program directed at IL-4.
Medicenna Therapeutics Corp. MDNAF
- bizaxofusp — Recurrent Glioblastoma Phase 2
Turn Therapeutics Inc. TTRX
- GX-03 — Atopic Dermatitis Phase 2